{"id":3509,"date":"2016-07-12T10:10:48","date_gmt":"2016-07-12T14:10:48","guid":{"rendered":"https:\/\/medicarereport.org\/?p=3509"},"modified":"2016-07-12T10:10:48","modified_gmt":"2016-07-12T14:10:48","slug":"a-fair-plan-for-fairer-drug-prices","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=3509","title":{"rendered":"A Fair Plan For Fairer Drug Prices"},"content":{"rendered":"<p>(By Scott Gottlieb and Kavita Patel for Health Affairs Blog posted July 11, 2016)<\/p>\n<p>As the biological basis of more diseases are fully revealed, and the drugs targeting medical problems become more focused and effective, more patients are finding themselves on <a href=\"https:\/\/aspe.hhs.gov\/sites\/default\/files\/pdf\/187586\/Drugspending.pdf\" target=\"_blank\">costlier specialty medicines<\/a>. At the same time, consumers find themselves paying a growing portion of their drug bills out of pocket as the structure of insurance changes. These two developments have combined to result in significant consumer hardship. <a href=\"http:\/\/healthaffairs.org\/blog\/2016\/07\/11\/a-fair-plan-for-fairer-drug-prices\/\" target=\"_blank\">Read article here&#8230;&#8230;<\/a><\/p>\n<p><span style=\"font-family: 'Arial','sans-serif';\"><span style=\"color: #000000;\">Copyright \u00a92015\u00a0<em>Health Affairs<\/em><\/span><span style=\"color: #000000;\"> by Project HOPE \u2013 The People-to-People Health Foundation, Inc.<\/span><\/span><\/p>\n<p><span style=\"color: #878787; font-family: 'Arial','sans-serif';\">.<\/span><\/p>\n<pre><strong>Notice<\/strong>: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/pre>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>(By Scott Gottlieb and Kavita Patel for Health Affairs Blog posted July 11, 2016) As the biological basis of more<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[16,6,15],"tags":[],"class_list":["post-3509","post","type-post","status-publish","format-standard","hentry","category-medicaid","category-medicare-general","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/3509","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3509"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/3509\/revisions"}],"predecessor-version":[{"id":3510,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/3509\/revisions\/3510"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3509"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=3509"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=3509"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}